1. Home
  2. HMY vs RDY Comparison

HMY vs RDY Comparison

Compare HMY & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harmony Gold Mining Company Limited

HMY

Harmony Gold Mining Company Limited

HOLD

Current Price

$16.51

Market Cap

12.7B

ML Signal

HOLD

Logo Dr. Reddy's Laboratories Ltd

RDY

Dr. Reddy's Laboratories Ltd

HOLD

Current Price

$13.34

Market Cap

11.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HMY
RDY
Founded
1950
1984
Country
South Africa
India
Employees
34350
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.7B
11.6B
IPO Year
N/A
2001

Fundamental Metrics

Financial Performance
Metric
HMY
RDY
Price
$16.51
$13.34
Analyst Decision
Buy
Strong Buy
Analyst Count
2
1
Target Price
$16.00
$16.90
AVG Volume (30 Days)
5.0M
2.2M
Earning Date
02-04-2016
05-08-2026
Dividend Yield
1.00%
0.54%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$37.77
$7.81
Revenue Next Year
$28.06
$3.20
P/E Ratio
$15.60
$18.67
Revenue Growth
N/A
N/A
52 Week Low
$13.03
$12.82
52 Week High
$26.04
$16.17

Technical Indicators

Market Signals
Indicator
HMY
RDY
Relative Strength Index (RSI) 50.35 42.67
Support Level $16.06 $13.32
Resistance Level $21.83 $14.14
Average True Range (ATR) 0.70 0.23
MACD 0.46 -0.04
Stochastic Oscillator 71.56 43.86

Price Performance

Historical Comparison
HMY
RDY

About HMY Harmony Gold Mining Company Limited

Harmony Gold Mining Co Ltd is engaged in gold mining and related activities, including exploration, extraction, and processing. The group's primary product is gold bullion, produced at operations in South Africa and Papua New Guinea. Gold byproducts include uranium and silver. Strategic projects such as the Wafi-Golpu Project in the New Guinea Mobile Belt, the Eva Copper Project in the Mt Isa Inlier, Queensland, Australia, and the MAC Copper acquisition position the company as a gold-copper producer. The company operates across South Africa, Papua New Guinea, and Australia.

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Share on Social Networks: